Ozempic and Similar Drugs: Weight-Loss Miracle or Health Risk?
Ozempic and Mounjaro: rapid weight loss with serious risks. FDA black box warning, weight regain, and natural alternatives. Analysis without filters.
English · Original discussion in Spanish · Published
Ozempic and similar drugs: miracle or health risk?
The FDA has issued a "black box" warning for Ozempic and Mounjaro due to the risk of thyroid tumors in rodents. While social media is flooded with "before and after" photos antiestéticaturing tanning and good lighting, the folds of excess skin and possible side effects are left out of the frame. The debate about these drugs goes beyond aesthetics: it touches on the medicalization of obesity, pharmacological dependence, and real alternatives.
The promise of rapid loss
Testimonials of losing 15 to 20 kilos in a few months are common. But so is regaining the weight after stopping treatment. "As soon as she stopped injecting herself, she kept eating as before and got just as fat again," it is noted. The drug reduces appetite but does not eliminate the need for emotional gratification through food. Those who stop treatment without changing habits regain the lost weight.
The risks that don't show up on Instagram
Safety warnings are serious: apart from possible thyroid cancer, effects such as excess skin, pancreatitis, and psychological dependence are mentioned. Some argue that "self-discipline and self-control" are preferable to "medications to wipe out half the fat people." However, there are also those who acknowledge that obesity is not just a matter of willpower, but that factors such as depression or addiction come into play.
Competing alternatives
Faced with GLP-1 agonists, options such as a strict carnivore diet, intermittent fasting, or even metformin, with which one user lost 8 kg in 6 months, are emerging. The debate is not settled: while some defend the efficiency of the drugs, others distrust the intentions of pharmaceutical companies and advocate for sustainable lifestyle changes.
The question left in the air is whether these medications are a useful tool under medical supervision or a dangerous fad that creates dependence and does not address the root causes of obesity.
Related debates in the forum
The FDA has issued a "black box" warning for Ozempic and Mounjaro due to the risk of thyroid tumors in rodents. While social media is flooded with "before and after" photos antiestéticaturing tanning and good lighting, the folds of excess skin and possible side effects are left out of the frame. The debate about these drugs goes beyond aesthetics: it touches on the medicalization of obesity, pharmacological dependence, and real alternatives.
The promise of rapid loss
Testimonials of losing 15 to 20 kilos in a few months are common. But so is regaining the weight after stopping treatment. "As soon as she stopped injecting herself, she kept eating as before and got just as fat again," it is noted. The drug reduces appetite but does not eliminate the need for emotional gratification through food. Those who stop treatment without changing habits regain the lost weight.
The risks that don't show up on Instagram
Safety warnings are serious: apart from possible thyroid cancer, effects such as excess skin, pancreatitis, and psychological dependence are mentioned. Some argue that "self-discipline and self-control" are preferable to "medications to wipe out half the fat people." However, there are also those who acknowledge that obesity is not just a matter of willpower, but that factors such as depression or addiction come into play.
Competing alternatives
Faced with GLP-1 agonists, options such as a strict carnivore diet, intermittent fasting, or even metformin, with which one user lost 8 kg in 6 months, are emerging. The debate is not settled: while some defend the efficiency of the drugs, others distrust the intentions of pharmaceutical companies and advocate for sustainable lifestyle changes.
The question left in the air is whether these medications are a useful tool under medical supervision or a dangerous fad that creates dependence and does not address the root causes of obesity.
Related debates in the forum
- Boom! In Denmark, 81.5% of cars sold in April are electric · 18 replies
- The bottle of whisky · 19 replies
- The thing about girls getting tattoos above their knees... · 18 replies
- Today I went out without my phone for a 2-hour walk and felt good (and didn't die, to the system's surprise) · 67 replies
Summary of a discussion on Burbuja.info - Foro de economía, actualidad y política., translated from Spanish and reviewed before publication. Read the full discussion (27 replies).
More summaries
-
The €3.61 Fee Killing AliExpress Purchases
The €3.61 per-category tariff has inflated AliExpress purchases by up to 80%. Consumers are stopping buys, and revenue is falling. Does it actually protect...
-
Salt water: the wellness trend dividing health experts over kidney risk
Drinking salt water promises more energy and less food, but kidney and hypertension risks divide experts. Data, testimonials and the science behind it…
-
Nutritionist fails to help client lose weight
A user describes a month and a half on a diet without losing weight, sparking a forum debate on nutrition, metabolism and willpower.
-
Free custom calisthenics: '3 years to understand your body'
An instructor offers free personalized calisthenics routines: two months of classes, bodyweight legs, and the balance between genetics and consistency.
-
Car insurance: choose your own repair shop or use the insurer's?
Should you pay €100 extra to choose your own repair shop or trust the insurer's network? We analyze the pros and cons with real data: savings vs. quality.
-
MacBook Air M5 vs Windows: best laptop for €1,500?
MacBook Neo with 8GB RAM or MacBook Air M5 with 16GB: the real doubt is memory. The refurbished ThinkPad enters the fight.